Phillips P H, Newman N J, Lynn M J
Department of Ophthalmology, Emory University School of Medicine, Atlanta, Ga, USA.
Arch Neurol. 1998 Feb;55(2):186-92. doi: 10.1001/archneur.55.2.186.
To describe the clinical profile of demyelinating optic neuritis in African Americans.
The medical records of all patients with a diagnosis of optic neuritis examined at the Neuro-Ophthalmology Unit at the Emory University Eye Center (Emory) and at the Grady Memorial Hospital Eye Clinic (Grady), Atlanta, Ga, between 1989 and 1996 were retrospectively reviewed.
African American and white patients, aged 15 through 55 years, with a single initial episode of acute optic neuritis of unknown or demyelinative origin were included in the study. Study patients included 23 African American patients and 56 white patients examined at Emory as well as 10 African American patients examined at Grady.
There were no significant differences among the African American study patients, the white study patients, and patients from the Optic Neuritis Treatment Trial (ONTT) regarding sex (P=.36), age (P=.73), or the presence of disc edema (P=.40), lesions found on magnetic resonance imaging (P=.43), or multiple sclerosis (P=.54) at the onset of an initial episode of optic neuritis. The Emory African American patients presented with more frequent severe visual loss (13 [93%] of 14 patients with a visual acuity < or =20/200) compared with Emory white patients (12 [39%] of 31 patients; P=.002) and with ONTT patients (161 [36%] of 448 patients; P<.001). At follow-up examination of at least 1 year, Emory African American patients had worse vision (9 [39%] of 23 patients <20/40, and 4 [17%] of 23 patients < or =20/200) compared with Emory white patients (5 [8%] of 63 patients <20/40, P=.001; 3 [5%] of 63 patients < or =20/200, P=.08), and with ONTT patients (29 [7%] of 409 patients <20/ 40, P=.0001; 12 [3%] of 409 patients < or =20/200, P=.01). Compared with ONTT patients, the Emory African American patients combined with the Grady African American patients had more frequent severe visual loss (visual acuity < or =20/200) at presentation (18 [90%] of 20 patients vs 161 [36%] of 448 patients; P<.001) and at follow-up examination of at least 1 year (6 [18%] of 33 patients vs 12 [3%] of 409 patients; P=.002). Seven (58%) of 12 African American patients with multiple sclerosis had a "neuromyelitis optica" presentation defined by the presence of neurological deficits limited to the optic nerves and spinal cord.
The African American study patients with a single episode of demyelinating optic neuritis had visual acuities more severely affected at onset and after 1 year of follow-up compared with the white study patients and with patients in the ONTT. In the African American patients, multiple sclerosis occurred most frequently in a "neuromyelitis optica" form.
描述非裔美国人脱髓鞘性视神经炎的临床特征。
回顾性分析1989年至1996年间在佐治亚州亚特兰大市埃默里大学眼科中心神经眼科单元(埃默里)和格雷迪纪念医院眼科诊所(格雷迪)接受检查且诊断为视神经炎的所有患者的病历。
纳入年龄在15至55岁之间、首次发生急性视神经炎且病因不明或为脱髓鞘性的非裔美国人和白人患者。研究患者包括在埃默里接受检查的23名非裔美国患者和56名白人患者,以及在格雷迪接受检查的10名非裔美国患者。
非裔美国研究患者、白人研究患者以及视神经炎治疗试验(ONTT)患者在性别(P = 0.36)、年龄(P = 0.73)、视盘水肿情况(P = 0.40)、磁共振成像发现的病变(P = 0.43)或视神经炎首发时的多发性硬化情况(P = 0.54)方面均无显著差异。与埃默里白人患者(31例患者中的12例[39%];P = 0.002)以及ONTT患者(448例患者中的161例[36%];P < 0.001)相比,埃默里非裔美国患者出现严重视力丧失的情况更为频繁(14例视力≤20/200的患者中的13例[93%])。在至少1年的随访检查中,与埃默里白人患者(63例患者中的5例[8%]<20/40,P = 0.001;63例患者中的3例[5%]≤20/200,P = 0.08)以及ONTT患者(409例患者中的29例[7%]<20/40,P = 0.0001;409例患者中的12例[3%]≤20/200,P = 0.01)相比,埃默里非裔美国患者的视力更差(23例患者中的9例[39%]<20/40,23例患者中的4例[17%]≤20/200)。与ONTT患者相比,埃默里非裔美国患者与格雷迪非裔美国患者合并后,在就诊时(20例患者中的18例[90%]对比448例患者中的161例[36%];P < 0.001)以及至少1年的随访检查时(33例患者中的6例[18%]对比409例患者中的12例[3%];P = 0.002)出现严重视力丧失(视力≤20/200)的情况更为频繁。12例患有多发性硬化的非裔美国患者中有7例(58%)表现为“视神经脊髓炎”,其定义为神经功能缺损仅限于视神经和脊髓。
与白人研究患者及ONTT患者相比,单次发作脱髓鞘性视神经炎的非裔美国研究患者在发病时及随访1年后视力受到的影响更为严重。在非裔美国患者中,多发性硬化最常表现为“视神经脊髓炎”形式。